Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

NCT00763035 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Potential participants with COPD/asthma unwilling to participate.

Conditions

Coronary Artery Disease
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Angina

Interventions

DRUG: Regadenoson
DRUG: Dobutamine

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]